Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Sara Tolaney, MD, MPH

Susan F. Smith Center for Women’s Cancers, Dana Farber Institute, Boston, MA

Presented by METAvivors of NJ in Memory of Donna Karlis

Enhancing the immunogenicity of PD-L1+ metastatic HR+ breast cancer via DNA damage

Evanthia Roussos Torres, MD, PhD

University of Southern California, Keck School of Medicine, USC Norris Comprehensive Cancer Center

The Geaton & JoAnn DeCesaris Family Foundation Grant in memory of Kimberly Stafford

Bi-directional translation of differences in the immunosuppressive tumor microenvironment of primary versus metastatic HER2+ breast cancer

Thu Truong, PhD

University of Minnesota, Masonic Cancer Center

Presented by MetaRaise DENJPA in Memory of Our Friend Patty Ann Baldwin

Progesterone receptor reprograms metabolic pathways to drive therapy resistant populations in metastatic breast cancer

MAXINE UMEH-GARCIA, PHD

University of California, Davis

Presented In memory of Tonyia Lucas

Mapping and Modulating the Brain Tumor Microenvironment (TME) to Unlock Therapeutic Potential in Breast Cancer Brain Metastases (BrMets)

Ines Velazquez-Quesada, PhD

Temple University, College of Engineering, Bioengineering Department

Presented in memory of Tonyia Lucas and her Hope To Find A Cure

Impact of the neuron – breast cancer cell interactions on the growth and survival of brain metastasis

Theresa Vincent, PhD

Grossman School of Medicine

Presented by The Met Gala Santa Clarita in honor of Eva Miranda Crawford and Amy Steffe Lohmann

Targeting breast cancer brain metastasis using a brain penetrable RNA Polymerase I inhibitor

Nikhil Wagle, MD

Dana-Farber Cancer Institute

Presented by #LightUpMBC Ambassador team in memory of Jessica Moore

Convergent transcriptional states in resistant ER+ metastatic breast cancer

KAY-UWE WAGNER, Phd

University of Nebraska Medical Center

Identification of Candidate Target Genes for Metastasis and Cancer Cell Dormancy in a Novel Triple-Negative Breast Cancer Model

HUA WANG, PHD

University of Illinois

Next-Generation Exosome Vaccines for Treating Metastatic Breast Cancer

REBECCA WATTERS, PhD

University of Pittsburgh

Discovery of Clinically Actionable Genes in Breast Cancer Bone Metastases

Christina Wei, MD

City of Hope National Medical Center

Presented by K and J Road To a Cure in honor of Kerry O’Riordan McAdam and Jacquie Reynolds Beck

Hepatic natural killer cell dysregulation facilitates breast cancer liver metastasis

Robert Weinberg, PhD

Whitehead Institute for Biomedical Research

Mechanisms of Acquired Adaptation of Disseminated Breast Cancer Cells